Helogen raises $7.1M before two October orbital biomaterial missions
Shishir Bankapur plans to put Helogen's seed financing behind HEL-IOS hardware, two October flights and the manufacturing data needed to pursue medical uses on Earth.
By Ryan Merket · Published
Primary source: FinSMEs
Why it matters
Helogen says its internal-material and customer missions already generate revenue, but it has not disclosed the scale. The October flights are expected to test the complete HEL-IOS platform for the first time and show whether its manufacturing records can support eventual medical-product review.
Shishir Bankapur, founder and CEO of Helogen, has raised a $7.1 million seed round to move his orbital biology venture from remotely operated experiments toward manufacturing biomaterials intended for medical implants. FinSMEs reported that RRE Ventures and Oceans co-led the financing, with One Way Ventures and Blisce participating.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.